[Skip to Navigation]
Sign In
From The Medical Letter on Drugs and Therapeutics
June 6, 2017

Prevention of Migraine

JAMA. 2017;317(21):2230-2231. doi:10.1001/jama.2017.1680

Patients with frequent or severe migraine headaches and those who cannot take vasoconstrictors or are refractory to acute treatment should receive preventive treatment.1,2 Menstrual migraine attacks may sometimes be prevented by a brief course of an NSAID or triptan, particularly frovatriptan or naratriptan, taken for several days before and after the onset of menstruation.3,4 Preventive therapy is generally not recommended during pregnancy.

Add or change institution